Healthtech startup Cloudbreak Health scores $10M growth funding to expand its telemedicine footprint
Cloudbreak Health, a Los Angeles-based health technology startup and provider of unified telemedicine and video medical interpretation solutions, has secured a $10 million investment from Columbia Partners Private Capital (“Columbia”) to fuel growth and product innovation. In conjunction with the funding, Cloudbreak also announced that Saul Waller, vice president at Columbia, will join its board as an observer.
Founded in 2003 by Andrew Panos and Jamey Edwards, Cloudbreak reduces the barriers to care by deploying powerful technology to address the disparities of language access and distance. Cloudbreak helps health systems and providers connect, communicate and care for their patients through its unified telemedicine platforms. Cloudbreak currently performs over 85,000 encounters per month on over 10,000 video endpoints at over 1,200 healthcare venues nationwide.
“Partnering with Columbia allows us to invest in the further expansion of our telemedicine solutions while expanding our IT, sales and customer service teams,” said Cloudbreak CEO Jamey Edwards. “In line with our mission to resolve healthcare disparities, we will add resources to our interpreter network and expand our technical team to support innovation in the next phase of scalability, product development and interoperability.”
From telepsychiatry, telestroke, tele-ICU, telesitting and other specialties to integrated language services for Limited English Proficient and Deaf/Hard-of-Hearing patients, Cloudbreak’s secure platform removes both distance and language barriers to improve patient care, satisfaction and outcomes. Cloudbreak Health provides more than one million minutes of telemedicine consultation each month.
“Cloudbreak brings unique insight into the nuances of delivering care to improve patients’ lives,” said Saul Waller, vice president at Columbia. “Cloudbreak’s track record of enabling care delivery in a way that is more caring and more cost-effective was a critical factor in our decision to invest.”